Annovis Bio, Inc. (FRA:07X)
Germany flag Germany · Delayed Price · Currency is EUR
3.920
+0.225 (6.09%)
At close: Dec 4, 2025

Annovis Bio Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
1046717410312542
Upgrade
Market Cap Growth
16.44%-61.39%69.23%-18.07%194.78%-
Upgrade
Enterprise Value
9155168738335
Upgrade
Last Close Price
3.974.9618.0012.1415.805.30
Upgrade
PB Ratio
9.247.46-24.763.873.206.89
Upgrade
P/TBV Ratio
9.247.46-3.873.206.89
Upgrade
Quick Ratio
4.092.721.353.6930.3313.96
Upgrade
Current Ratio
4.603.592.394.6830.5414.04
Upgrade
Return on Equity (ROE)
-246.14%-3159.09%-546.40%-69.57%-55.68%-180.82%
Upgrade
Return on Assets (ROA)
-105.88%-138.26%-121.77%-38.88%-33.58%-89.86%
Upgrade
Return on Capital (ROIC)
-165.21%-2143.41%-273.63%-43.79%-34.92%-126.89%
Upgrade
Return on Capital Employed (ROCE)
-198.60%-265.80%-759.60%-90.10%-32.70%-88.10%
Upgrade
Earnings Yield
-20.46%-35.43%-29.29%-23.10%-10.17%-10.51%
Upgrade
Buyback Yield / Dilution
-61.36%-35.60%-10.55%-7.03%-20.88%-2132.36%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.